Diffuse Intrinsic Pontine Glioma — Trials

Diffuse Intrinsic Pontine Glioma — Trials · CancerIndex

Clinical trials

Registered studies

111 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 48
Recruiting: 25
Ph III recruiting: 1
Growth YoY: —
Industry share: 15%
Top sponsor: Nationwide Children's Hospital
Termination share: 39%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (19)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04532229	Nimotuzumab in Combined With Chemoradiotherapy to Treat the Newly Diagnosed Diffuse Intrinsic Pontine Glioma in Children	unknown	Phase 3	48	Biotech Pharmaceutical Co., Ltd.OTHER	1	Jul 27, 2023	clinicaltrials
NCT03243461	International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013)(HIT-HGG-2013)	unknown	Phase 3	167	University of GöttingenOTHER	1	Jun 6, 2022